Can a new catheter make heart stenting safer and more effective?

NCT ID NCT07742345

Recruiting now Disease control Sponsor: BrosMed Medical Co., Ltd Source: ClinicalTrials.gov ↗

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial is testing a new coronary extension catheter designed to help doctors deliver balloons and stents more easily during percutaneous coronary intervention (PCI) for coronary artery disease. The study will enroll about 69 adults who need PCI and for whom the catheter is planned to assist the procedure. Researchers will measure how often the device successfully delivers the stent, overall procedural success, and safety outcomes during follow-up.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Coronary extension catheter (a device used during percutaneous coronary intervention to help deliver balloons and stents to the target lesion)
What this could lead to: If successful, this catheter could make complex coronary stenting procedures safer and more effective, potentially improving outcomes for people with coronary artery disease.
What could go wrong: This is a small, single-arm study without a comparison group, so results may not be definitive. As with any invasive procedure, there are risks such as vessel damage or complications during PCI.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE (CAD) PERCUTANEOUS CORONARY INTERVENTION (PCI)

Contacts and locations

Locations

Beijing Friendship Hospital, Capital Medical University
RECRUITING

Beijing, 100050, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.